National Health Investors Inc (NHI) Position Reduced by Strs Ohio

Strs Ohio lessened its stake in National Health Investors Inc (NYSE:NHI) by 2.6% in the 3rd quarter, HoldingsChannel reports. The fund owned 67,045 shares of the real estate investment trust’s stock after selling 1,778 shares during the quarter. Strs Ohio’s holdings in National Health Investors were worth $5,067,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Dimensional Fund Advisors LP grew its holdings in shares of National Health Investors by 5.1% during the first quarter. Dimensional Fund Advisors LP now owns 629,717 shares of the real estate investment trust’s stock worth $42,374,000 after buying an additional 30,317 shares in the last quarter. UBS Group AG grew its holdings in shares of National Health Investors by 1.0% during the first quarter. UBS Group AG now owns 70,004 shares of the real estate investment trust’s stock worth $4,710,000 after buying an additional 714 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its holdings in shares of National Health Investors by 54.3% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 47,247 shares of the real estate investment trust’s stock worth $3,180,000 after buying an additional 16,629 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of National Health Investors by 10.7% during the first quarter. Legal & General Group Plc now owns 133,324 shares of the real estate investment trust’s stock worth $8,971,000 after buying an additional 12,889 shares in the last quarter. Finally, Xact Kapitalforvaltning AB grew its holdings in shares of National Health Investors by 37.3% during the first quarter. Xact Kapitalforvaltning AB now owns 5,151 shares of the real estate investment trust’s stock worth $347,000 after buying an additional 1,400 shares in the last quarter. 68.55% of the stock is owned by institutional investors.

National Health Investors stock opened at $72.72 on Friday. The company has a quick ratio of 15.56, a current ratio of 15.56 and a debt-to-equity ratio of 0.90. National Health Investors Inc has a 52-week low of $62.71 and a 52-week high of $81.60. The firm has a market cap of $3.07 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 3.11 and a beta of 0.34.



National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, August 7th. The real estate investment trust reported $0.91 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.05). National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. The firm had revenue of $72.96 million during the quarter, compared to analysts’ expectations of $73.80 million. Equities research analysts anticipate that National Health Investors Inc will post 5.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 9th. Investors of record on Friday, September 28th will be issued a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.50%. The ex-dividend date of this dividend is Thursday, September 27th. National Health Investors’s dividend payout ratio is currently 75.05%.

NHI has been the subject of a number of research reports. Wells Fargo & Co reaffirmed a “hold” rating on shares of National Health Investors in a report on Tuesday, August 28th. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a report on Wednesday, July 25th. Cantor Fitzgerald upped their target price on shares of National Health Investors from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, August 8th. SunTrust Banks reaffirmed a “hold” rating and set a $79.00 target price on shares of National Health Investors in a report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 target price on shares of National Health Investors and gave the stock a “buy” rating in a report on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $75.22.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: Investing in Dividend Stocks

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply